US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Virtus LifeSci Biotech Products ETF

104.76

+3.523.48%

Post-market: 104.790.0336+0.03%17:10 EDT

Volume:9K

Turnover:922.39K

Market Cap:130.95M

PE:- -

High:105.12

Open:101.84

Low:101.84

Close:101.24

52wk High:110.05

52wk Low:70.27

Shares:1.25M

Float Shares:1.25M

Volume Ratio:0.52

T/O Rate:0.71%

Dividend:- -

Dividend Rate:- -

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Rising Interest Rates: the Good, the Bad and the Ugly for Retirees

Retension Pharmaceuticals Debuts on US Stock Market, Shares Drop Over 10% After Opening

TRex Bio indicated to open at $14.50, IPO priced at $14

Teva announces FDA approval for Weltruza

Island Pharmaceuticals Expands Unquoted Employee Options Pool

Linical Wins $20 Million U.S. Biotech Order as FDA Environment Normalizes

The Good, the Bad and the Ugly of Rising Interest Rates

South Korea's Biopharmaceutical Exports Hit Record $6.6 Billion in First Nine Months

Novartis announces FDA approval of Rhapsido for symptomatic dermographism

Novartis Rhapsido® (remibrutinib) receives FDA approval as first treatment for symptomatic dermographism (SD), expanding its use beyond chronic spontaneous urticaria (CSU)

This Part of the Bond Market Offers Compelling Yields with Minimal Risk

Alvotech and LOTTE Biologics announce US-based manufacturing agreement to increase global supply

Kamada Announces Expansion of Biosimilars Portfolio with the Launch of Two Additional Products in Israel

Wall Street is booming. Surging yields could shake things up

BridgeBio Says Interim Analysis of BBP-418 Showed Individuals Reaching Normal Levels on Limb-Girdle Muscular Dystrophy Markers

MT Newswires Live

BBP-418 Demonstrates Potential to Be Disease Modifying Therapy, Restoring Cardiac and Disease Markers to Unaffected Levels

FDA approves additional U.S. manufacturing capacity for SIMLANDI®, Alvotech’s biosimilar to Humira®

Press Release: Celcuity Appoints David Gryska to Its Board of Directors

Abogen announces licensing, option agreement with Novartis

The Hidden Silver Lining of High Interest Rates: Safer, Cheaper Retirement Income

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/BBP/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BBP","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBP\",,,,,undefined,":{"symbol":"BBP","market":"US","secType":"STK","nameCN":"Virtus LifeSci Biotech Products ETF","latestPrice":104.7564,"timestamp":1791576000000,"preClose":101.2354,"halted":0,"volume":8884,"hourTrading":{"tag":"盘后","latestPrice":104.79,"preClose":104.7564,"latestTime":"17:10 EDT","volume":24,"amount":2518.442,"timestamp":1791580247026,"change":0.0336,"changeRate":0.000321,"amplitude":0},"delay":0,"changeRate":0.0347803238788013,"floatShares":1250004,"shares":1250004,"eps":0,"marketStatus":"Market Closed","change":3.521,"latestTime":"10-09 16:00:00 EDT","open":101.84,"high":105.12,"low":101.84,"amount":922390,"amplitude":0.0324,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791792000000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":101.2354,"sharesOutstanding":600004,"nav":101.653,"aum":127066692.32,"bidAskSpread":0.002364,"postHourTrading":{"tag":"盘后","latestPrice":104.79,"preClose":104.7564,"latestTime":"17:10 EDT","volume":24,"amount":2518.442,"timestamp":1791580247026,"change":0.0336,"changeRate":0.000321,"amplitude":0},"volumeRatio":0.5237741893690447,"impliedVol":0.2112,"impliedVolPercentile":0.1992},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBP\",,,,,undefined,":{"symbol":"BBP","floatShares":1250004,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.5237741893690447,"shares":1250004,"dividePrice":0,"high":105.12,"amplitude":0.0324,"preClose":101.2354,"low":101.84,"week52Low":70.27,"pbRate":"--","week52High":110.05,"institutionHeld":0,"latestPrice":104.7564,"eps":0,"divideRate":0,"volume":8884,"delay":0,"ttmEps":0,"open":101.84,"prevYearClose":79.9149,"prevWeekClose":102.4978,"prevMonthClose":105.5872,"prevQuarterClose":105.5872,"fiveDayClose":102.4978,"twentyDayClose":103.4597,"sixtyDayClose":96.9243},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BBP\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BBP\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BBP\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BBP\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2674818244","title":"Rising Interest Rates: the Good, the Bad and the Ugly for Retirees","url":"https://stock-news.laohu8.com/highlight/detail?id=2674818244","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674818244?lang=en_us&edition=fundamental","pubTime":"2026-10-11 03:45","pubTimestamp":1791661500,"startTime":"0","endTime":"0","summary":"Unlike higher gas prices, which hurt almost everyone, higher borrowing costs have an uneven impactRising interest rates can upend the finances of some seniors.In September 2024, Donald Trump, then the","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TSLY","CAOS","CGDV","CRSH","PEVC","TLA","07366","TESC","BBP","TSLZ","UCC","BK4588","IJK","09766","FXL","RJZ","TSLS","CLIX","09366","TSII","KOMP","TSLO","TSLI","VAW","ELOL","TSDD","DFUV","TSLW","TSYY","TSLL","TSLG","07766","ANEW","BK4585","TSLP","TSLR","TESL","TSL","FXR","TSLQ","TEST","AVSD","TSLT","LRCY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1144830990","title":"Retension Pharmaceuticals Debuts on US Stock Market, Shares Drop Over 10% After Opening","url":"https://stock-news.laohu8.com/highlight/detail?id=1144830990","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1144830990?lang=en_us&edition=fundamental","pubTime":"2026-10-10 00:28","pubTimestamp":1791563294,"startTime":"0","endTime":"0","summary":"According to reports, on Friday, Retension Pharmaceuticals Inc (RTSN.US) listed on the US stock market. As of press time, the stock had fallen more than 10% to $10.77. The IPO price was $12.Retension...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRNX","RTSN","MRNY","BBP","03069","IBBQ","BK1610"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674686768","title":"TRex Bio indicated to open at $14.50, IPO priced at $14","url":"https://stock-news.laohu8.com/highlight/detail?id=2674686768","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674686768?lang=en_us&edition=fundamental","pubTime":"2026-10-09 22:45","pubTimestamp":1791557133,"startTime":"0","endTime":"0","summary":"TRex Bio (TRXB), a clinical-stage biotechnology company focused on tissue Treg biology for the discovery and development of immunoregulatory medici...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/trex-bio-indicated-to-open-at-14-50-ipo-priced-at-14-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/trex-bio-indicated-to-open-at-14-50-ipo-priced-at-14-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4127","BBP","FHLC","TRXB","BK4588","FWD","IEIH","REDS","FRHC","IPOS","LNGR","BK4585","RSPH","BBC","KCE","JDOC","DARP","SYNB","IBB","XT","AGNG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674785642","title":"Teva announces FDA approval for Weltruza","url":"https://stock-news.laohu8.com/highlight/detail?id=2674785642","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674785642?lang=en_us&edition=fundamental","pubTime":"2026-10-09 19:05","pubTimestamp":1791543924,"startTime":"0","endTime":"0","summary":"Teva (TEVA) announced that the FDA has approved Weltruza for extended-release injectable suspension, a new, once-monthly, subcutaneous long-acting ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/teva-announces-fda-approval-for-weltruza-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/teva-announces-fda-approval-for-weltruza-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PSCH","LFSC","TEVA","MRNY","GDOC","BK4588","BK4566","BK4007","IYH","XLVX","BBP","BK4596","IDNA","MEDI","TECB","BMED","LABU","NVIB","BK4557","IBB","LU2324357040.USD","FRTY","BK4584","IEIH","SYNB","GNMX","TBXU","RSPH","LU1983299246.USD","PINK","BK4559","BK4585","MRNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674887029","title":"Island Pharmaceuticals Expands Unquoted Employee Options Pool","url":"https://stock-news.laohu8.com/highlight/detail?id=2674887029","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674887029?lang=en_us&edition=fundamental","pubTime":"2026-10-09 11:17","pubTimestamp":1791515857,"startTime":"0","endTime":"0","summary":"The latest update is out from Island Pharmaceuticals Ltd ( ($AU:ILA) ). Island Pharmaceuticals Ltd is an ASX-listed biotechnology company focused o...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/island-pharmaceuticals-expands-unquoted-employee-options-pool?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/island-pharmaceuticals-expands-unquoted-employee-options-pool?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IBB","XT","FWD","JDOC","DARP","RSPH","BK4585","LNGR","IEIH","BBP","AGNG","BK4588","SYNB","FHLC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674184887","title":"Linical Wins $20 Million U.S. Biotech Order as FDA Environment Normalizes","url":"https://stock-news.laohu8.com/highlight/detail?id=2674184887","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674184887?lang=en_us&edition=fundamental","pubTime":"2026-10-09 10:52","pubTimestamp":1791514334,"startTime":"0","endTime":"0","summary":"Linical Co., Ltd. ( ($JP:2183) ) has issued an update. Linical Co., Ltd. has secured a large new order from a U.S. biotechnology company worth 20.4...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/linical-wins-20-million-u-s-biotech-order-as-fda-environment-normalizes?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/linical-wins-20-million-u-s-biotech-order-as-fda-environment-normalizes?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBIX","SYNB","BBP","BK4585","RSPH","FWD","LNGR","PBE","BK4588","BK4581","FHLC","DARP","XBI","JDOC","LABU","AGNG","XT","IBB","IEIH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674600983","title":"The Good, the Bad and the Ugly of Rising Interest Rates","url":"https://stock-news.laohu8.com/highlight/detail?id=2674600983","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674600983?lang=en_us&edition=fundamental","pubTime":"2026-10-08 23:59","pubTimestamp":1791475140,"startTime":"0","endTime":"0","summary":"Unlike higher gas prices, which hurt almost everyone, higher borrowing costs have an uneven impactRising interest rates can upend the finances of some seniors.In September 2024, Donald Trump, then the","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","CAOS","TSLQ","07366","TLA","TSLP","09366","CRSH","TSLR","TSYY","BBP","TSL","09766","CLIX","RJZ","TSLI","TSLG","TESL","ELOL","TSLS","KOMP","TESC","TEST","TSLW","TSLZ","IJK","PEVC","TSII","CGDV","UCC","AVSD","TSLL","07766","DFUV","FXL","VAW","BK4588","FXR","TSLT","TSDD","ANEW","LRCY","TSLO","TSLY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1177332611","title":"South Korea's Biopharmaceutical Exports Hit Record $6.6 Billion in First Nine Months","url":"https://stock-news.laohu8.com/highlight/detail?id=1177332611","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1177332611?lang=en_us&edition=fundamental","pubTime":"2026-10-08 14:51","pubTimestamp":1791442284,"startTime":"0","endTime":"0","summary":"South Korea's biopharmaceutical exports reached a record high of $6.6 billion in the first nine months of this year, driven by robust demand from the European market, according to government data...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1610","MRNX","03069","BBP","MRNY","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673011517","title":"Novartis announces FDA approval of Rhapsido for symptomatic dermographism","url":"https://stock-news.laohu8.com/highlight/detail?id=2673011517","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673011517?lang=en_us&edition=fundamental","pubTime":"2026-10-07 23:50","pubTimestamp":1791388212,"startTime":"0","endTime":"0","summary":"Novartis (NVS) announced that the Food and Drug Administration approved Rhapsido as the first treatment for adults with symptomatic dermographism i...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/novartis-announces-fda-approval-of-rhapsido-for-symptomatic-dermographism-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/novartis-announces-fda-approval-of-rhapsido-for-symptomatic-dermographism-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PSCH","MEDX","LU0070302665.USD","XLVX","NVIB","LU0208291251.USD","IE00BJT1NW94.SGD","BMED","LFSC","IYH","LABU","FRTY","BK4585","BK4588","BBP","BK4007","MEDI","IEIH","TECB","GNMX","PINK","BK4578","MRNY","LU0320765489.SGD","IE0002141913.USD","IBB","SYNB","TBXU","GDOC","IDNA","BK4532","MRNX","IE00BFTCPJ56.SGD","IE0009355771.USD","IE00B4R5TH58.HKD","LU0211331839.USD","RSPH","NVS","IE00BJJMRZ35.SGD","PPH","IE00B2B36J28.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673118620","title":"Novartis Rhapsido® (remibrutinib) receives FDA approval as first treatment for symptomatic dermographism (SD), expanding its use beyond chronic spontaneous urticaria (CSU)","url":"https://stock-news.laohu8.com/highlight/detail?id=2673118620","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673118620?lang=en_us&edition=fundamental","pubTime":"2026-10-07 23:45","pubTimestamp":1791387900,"startTime":"0","endTime":"0","summary":"In Phase III RemIND trial, twice as many adults taking Rhapsido achieved complete hive resolution by Week 12 vs placebo, with responses seen by Week 21SD is most prevalent type of chronic inducible ur","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/10/07/3376686/0/en/novartis-rhapsido-remibrutinib-receives-fda-approval-as-first-treatment-for-symptomatic-dermographism-sd-expanding-its-use-beyond-chronic-spontaneous-urticaria-csu.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IAI","LU1064131342.USD","LU1720051108.HKD","LU0210528500.USD","LU1668664300.SGD","LU0528227936.USD","LU0267386448.USD","MEDI","PINK","LU2089284900.SGD","PSCH","KBWB","LU2357305700.SGD","LU2487616109.SGD","SD","TBXU","TECB","BK4581","LFSC","MRNX","LABU","BK4585","LU1720051017.SGD","LU0390134368.USD","NVIB","FRTY","IBB","BK4504","LU0912757837.SGD","BBP","LU1791710582.SGD","IEIH","LU2028103732.USD","BMED","MRNY","XLVX","LU1244550221.USD","LU0795875169.SGD","SYNB","RSPH","LU2023251221.USD","GDOC","LU2264538146.SGD","IE00BZ1G4Q59.USD","LU0106831901.USD","IE00B3S45H60.SGD","LU1989772840.SGD","IYH","GNMX","IDNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673472015","title":"This Part of the Bond Market Offers Compelling Yields with Minimal Risk","url":"https://stock-news.laohu8.com/highlight/detail?id=2673472015","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673472015?lang=en_us&edition=fundamental","pubTime":"2026-10-07 21:53","pubTimestamp":1791381180,"startTime":"0","endTime":"0","summary":"You can earn good yields with very low price risk in ultrashort bond fundsRisk-averse investors seeking more income than they can get with a money-market fund should consider ultrashort bond funds.At ","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CGDV","VAW","KOMP","US30Y.BOND","TLTW","QQQP","PEVC","TSLO","TSLQ","TSLW","TLT","CLIX","TSYY","BNDW","FXR","TSLI","UCC","DFUV","AVSD","US10Y.BOND","CRSH","RSEE","TMF","TSLR","TSLS","US6M.BOND","TEST","CAOS","TSLG","BBP","LVIG","TSL","US12M.BOND","TESL","ANEW","FXL","US5Y.BOND","IJK","US2Y.BOND","US3Y.BOND","US7Y.BOND","RJZ","JULD","ELOL","TSLP","LRCY","TLA","TSII","TSLY","TSDD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673065617","title":"Alvotech and LOTTE Biologics announce US-based manufacturing agreement to increase global supply","url":"https://stock-news.laohu8.com/highlight/detail?id=2673065617","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673065617?lang=en_us&edition=fundamental","pubTime":"2026-10-07 04:37","pubTimestamp":1791319020,"startTime":"0","endTime":"0","summary":"Alvotech and LOTTE Biologics signing ceremony to commemorate the formation of a strategic manufacturing agreement on October 6, 2026","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/10/06/3376052/0/en/alvotech-and-lotte-biologics-announce-us-based-manufacturing-agreement-to-increase-global-supply.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CDMO","ALVO","BK4139","BBP","EES"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673750053","title":"Kamada Announces Expansion of Biosimilars Portfolio with the Launch of Two Additional Products in Israel","url":"https://stock-news.laohu8.com/highlight/detail?id=2673750053","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673750053?lang=en_us&edition=fundamental","pubTime":"2026-10-06 19:00","pubTimestamp":1791284400,"startTime":"0","endTime":"0","summary":"Company Expects Growing Biosimilar Product Portfolio, Commercialized in Israel and the MENA Region, to Generate Approximately $10 Million in Annual Revenue in 2028 and Approximately $20 Million-$25 Mi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/10/06/3375311/0/en/kamada-announces-expansion-of-biosimilars-portfolio-with-the-launch-of-two-additional-products-in-israel.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KMDA","BBP","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673030837","title":"Wall Street is booming. Surging yields could shake things up","url":"https://stock-news.laohu8.com/highlight/detail?id=2673030837","media":"CNN Business","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673030837?lang=en_us&edition=fundamental","pubTime":"2026-10-06 17:00","pubTimestamp":1791277245,"startTime":"0","endTime":"0","summary":"Wall Street rolled into 2026 on a hot streak and continued with a booming first half.Profits surged, fueled by massive spending on artificial intelligence, elevated trading activity in a volatile market and dealmaking that has benefited from a relaxed regulatory environment under the Trump administration.Wall Street hauled in $45.9 billion in profits in the first half of the year, up 51% from the same period a year ago, according to the New York State Comptroller’s latest report on the securities industry in New York City.At the current pace of growth, the industry’s profits in 2026 could exceed $90 billion for the full year — smashing through previous records and outpacing the inflation-adjusted record set in 2009.The boon for traders and bankers comes as AI investment is fueling US economic growth even as consumer sentiment hovers at historic lows due to concerns about the cost of living, from rising energy prices to stubborn food inflation.The AI boom, a pickup in M&A and a series o","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"cnn_highlight","url":"https://edition.cnn.com/2026/10/06/business/wall-street-profits-ai-boom","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://edition.cnn.com/2026/10/06/business/wall-street-profits-ai-boom","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"cnn_highlight","symbols":["KOMP","CHAT","AIPO","VTHR","CGDV","AGIX","ANEW","ARTY","IJK","LRCY","PEVC","BK4585","CLIX","QTOC","DFUV","BBP","CAOS","BK4588","VAW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673071677","title":"BridgeBio Says Interim Analysis of BBP-418 Showed Individuals Reaching Normal Levels on Limb-Girdle Muscular Dystrophy Markers","url":"https://stock-news.laohu8.com/highlight/detail?id=2673071677","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673071677?lang=en_us&edition=fundamental","pubTime":"2026-10-05 20:41","pubTimestamp":1791204109,"startTime":"0","endTime":"0","summary":"BridgeBio Pharma  said Monday that new exploratory cardiac data from the 12-month interim analysis of Fortify phase 3 study of oral BBP-418 showed individuals with limb-girdle muscular dystrophy type 2I/R9 reaching normal or near-normal levels on disease markers.Data demonstrated that all participants treated with BBP-418 returned to the normal range for HS troponin l, a blood test used to detect injury to heart muscle, by month 12, compared with 40% for the placebo arm, the company said.Additionally, 54% of participants treated with BBP-418 had stable or improved left ventricular ejection fraction, a measure of how much blood is being pushed out by the heart's main chamber with each beat, at month 12 versus 25% for those on placebo, BridgeBio Pharma said.BBP-418 is currently under the US Food and Drug Administration's priority review with a Prescription Drug User Fee Act target action date of Nov. 27, according to a statement.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","BBP","BBIO","BK4505","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673704062","title":"BBP-418 Demonstrates Potential to Be Disease Modifying Therapy, Restoring Cardiac and Disease Markers to Unaffected Levels","url":"https://stock-news.laohu8.com/highlight/detail?id=2673704062","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673704062?lang=en_us&edition=fundamental","pubTime":"2026-10-05 19:30","pubTimestamp":1791199800,"startTime":"0","endTime":"0","summary":"- In exploratory analyses at Month 12, among individuals with LGMD2I/R9 (FKRP-related) with elevated HS troponin I at baseline, 100% treated with BBP-418 returned to the normal range by Month 12 versu","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/10/05/3374437/0/en/bbp-418-demonstrates-potential-to-be-disease-modifying-therapy-restoring-cardiac-and-disease-markers-to-unaffected-levels.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EMA","BBP","BK4081"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673470582","title":"FDA approves additional U.S. manufacturing capacity for SIMLANDI®, Alvotech’s biosimilar to Humira®","url":"https://stock-news.laohu8.com/highlight/detail?id=2673470582","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673470582?lang=en_us&edition=fundamental","pubTime":"2026-10-05 16:00","pubTimestamp":1791187200,"startTime":"0","endTime":"0","summary":"Approval enables AVT02 drug substance for U.S. commercial supply to be manufactured in either of Alvotech’s two Reykjavik drug substance suites Further confirms resolution of FDA inspection-related ma","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/10/05/3374199/0/en/fda-approves-additional-u-s-manufacturing-capacity-for-simlandi-alvotech-s-biosimilar-to-humira.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VAI","BK4588","ALVO","AMER","BK4585","BK4582","BK4139","EES","MADE","BBP","GAST","BK4166","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672116477","title":"Press Release: Celcuity Appoints David Gryska to Its Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2672116477","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672116477?lang=en_us&edition=fundamental","pubTime":"2026-10-02 20:00","pubTimestamp":1790942400,"startTime":"0","endTime":"0","summary":"MINNEAPOLIS, Oct. 02, 2026 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a biotechnology company focused on developing and commercializing targeted therapies for the treatment of multiple solid tu","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4604","BK4139","03160","IDNA","MEDX","BK4555","TM","BK4588","CELC","BBP","SYNB","NVIB","HYLG","IBB","IEIH","BK4585","BK4099","RSPH","GDOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672163957","title":"Abogen announces licensing, option agreement with Novartis","url":"https://stock-news.laohu8.com/highlight/detail?id=2672163957","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672163957?lang=en_us&edition=fundamental","pubTime":"2026-10-02 18:10","pubTimestamp":1790935812,"startTime":"0","endTime":"0","summary":"Abogen Biosciences, a clinical-stage biotechnology group pioneering RNA innovation, announced that it has entered into a licensing and option agree...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/abogen-announces-licensing-option-agreement-with-novartis-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/abogen-announces-licensing-option-agreement-with-novartis-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LNGR","DARP","BK4139","AGNG","IBB","RSPH","BK4588","SYNB","IE0009354923.USD","IEIH","JDOC","RNA","BK4505","BK4585","XT","BBP","FHLC","BBC","FWD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672945767","title":"The Hidden Silver Lining of High Interest Rates: Safer, Cheaper Retirement Income","url":"https://stock-news.laohu8.com/highlight/detail?id=2672945767","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672945767?lang=en_us&edition=fundamental","pubTime":"2026-10-02 05:27","pubTimestamp":1790890020,"startTime":"0","endTime":"0","summary":"Annuity payout rates are closely tied to interest ratesHigher interest rates also mean that it takes less to secure the same retirement standard of living as before rates started rising.It's an ill wi","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ANEW","CRSH","DFUV","IJK","LJAN","THY","RJZ","QYLG","TSLG","LIAJ","VAW","FXL","CGDV","TSLQ","SETM","MDIV","AVSD","DFIP","FXR","TSLR","TSLI","TSLP","LIBD","LIAO","TSLO","HIPS","IBIB","STOT","CEFD","XYLD","WIA","PAYM","BBP","HIGH","TSYY","UCC","LCTO","XYLG","BALQ","TSDD","YLD","DRKY","CLIX","CAOS","LRCY","TSII","PEVC","KOMP","TESL","BUCK"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":1,"totalSize":200,"code":"91000000","status":"200"}]}}